Literature DB >> 21345917

Social cognition in schizophrenia, Part 1: performance across phase of illness.

Michael F Green1, Carrie E Bearden, Tyrone D Cannon, Alan P Fiske, Gerhard S Hellemann, William P Horan, Kimmy Kee, Robert S Kern, Junghee Lee, Mark J Sergi, Kenneth L Subotnik, Catherine A Sugar, Joseph Ventura, Cindy M Yee, Keith H Nuechterlein.   

Abstract

Social cognitive impairments are consistently reported in schizophrenia and are associated with functional outcome. We currently know very little about whether these impairments are stable over the course of illness. In the current study, 3 different aspects of social cognition were assessed (emotion processing, Theory of Mind [ToM], and social relationship perception) at 3 distinct developmental phases of illness: prodromal, first episode, and chronic. In this cross-sectional study, participants included 50 individuals with the prodromal risk syndrome for psychosis and 34 demographically comparable controls, 81 first-episode schizophrenia patients and 46 demographically comparable controls, and 53 chronic schizophrenia patients and 47 demographically comparable controls. Outcome measures included total and subtest scores on 3 specialized measures of social cognition: (1) emotion processing assessed with the Mayer-Salovey-Caruso Emotional Intelligence Test, (2) ToM assessed with The Awareness of Social Inference Test, and (3) social relationship perception assessed the Relationships Across Domains Test. Social cognitive performance was impaired across all domains of social cognition and in all clinical samples. Group differences in performance were comparable across phase of illness, with no evidence of progression or improvement. Age had no significant effect on performance for either the clinical or the comparison groups. The findings suggest that social cognition in these 3 domains fits a stable pattern that has outcome and treatment implications. An accompanying article prospectively examines the longitudinal stability of social cognition and prediction of functional outcome in the first-episode sample.

Entities:  

Mesh:

Year:  2011        PMID: 21345917      PMCID: PMC3406534          DOI: 10.1093/schbul/sbq171

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  52 in total

1.  Poor perception of nonverbal social-emotional cues in relatives of schizophrenic patients.

Authors:  R Toomey; L J Seidman; M J Lyons; S V Faraone; M T Tsuang
Journal:  Schizophr Res       Date:  1999-11-30       Impact factor: 4.939

2.  Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk.

Authors:  T H McGlashan; T J Miller; S W Woods
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

3.  Vulnerability--a new view of schizophrenia.

Authors:  J Zubin; B Spring
Journal:  J Abnorm Psychol       Date:  1977-04

4.  Is theory of mind in schizophrenia more strongly associated with clinical and social functioning than with neurocognitive deficits?

Authors:  Rita Roncone; Ian R H Falloon; Monica Mazza; Alessandro De Risio; Rocco Pollice; Stefano Necozione; PierLuigi Morosini; Massimo Casacchia
Journal:  Psychopathology       Date:  2002 Sep-Oct       Impact factor: 1.944

Review 5.  The endophenotype concept in psychiatry: etymology and strategic intentions.

Authors:  Irving I Gottesman; Todd D Gould
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

6.  Does social cognition influence the relation between neurocognitive deficits and vocational functioning in schizophrenia?

Authors:  Roland Vauth; Nicolas Rüsch; Markus Wirtz; Patrick W Corrigan
Journal:  Psychiatry Res       Date:  2004-09-30       Impact factor: 3.222

Review 7.  Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.

Authors:  Michael F Green; Keith H Nuechterlein; James M Gold; Deanna M Barch; Jonathan Cohen; Susan Essock; Wayne S Fenton; Fred Frese; Terry E Goldberg; Robert K Heaton; Richard S E Keefe; Robert S Kern; Helena Kraemer; Ellen Stover; Daniel R Weinberger; Steven Zalcman; Stephen R Marder
Journal:  Biol Psychiatry       Date:  2004-09-01       Impact factor: 13.382

8.  A heuristic vulnerability/stress model of schizophrenic episodes.

Authors:  K H Nuechterlein; M E Dawson
Journal:  Schizophr Bull       Date:  1984       Impact factor: 9.306

9.  Evidence of factorial variance of the Mayer-Salovey-Caruso Emotional Intelligence Test across schizophrenia and normative samples.

Authors:  Shaun M Eack; Michael F Pogue-Geile; Catherine G Greeno; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2009-06-06       Impact factor: 4.939

10.  Do the siblings of schizophrenia patients demonstrate affect perception deficits?

Authors:  Kimmy S Kee; William P Horan; Jim Mintz; Michael F Green
Journal:  Schizophr Res       Date:  2004-03-01       Impact factor: 4.939

View more
  116 in total

1.  An intact social cognitive process in schizophrenia: situational context effects on perception of facial affect.

Authors:  Junghee Lee; Robert S Kern; Philippe-Olivier Harvey; William P Horan; Kimmy S Kee; Kevin Ochsner; David L Penn; Michael F Green
Journal:  Schizophr Bull       Date:  2012-04-24       Impact factor: 9.306

Review 2.  Oxytocin and social cognition in affective and psychotic disorders.

Authors:  M Mercedes Perez-Rodriguez; Katie Mahon; Manuela Russo; Allison K Ungar; Katherine E Burdick
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

3.  Nonverbal social communication and gesture control in schizophrenia.

Authors:  Sebastian Walther; Katharina Stegmayer; Jeanne Sulzbacher; Tim Vanbellingen; René Müri; Werner Strik; Stephan Bohlhalter
Journal:  Schizophr Bull       Date:  2015-02-01       Impact factor: 9.306

4.  A novel, online social cognitive training program for young adults with schizophrenia: A pilot study.

Authors:  Mor Nahum; Melissa Fisher; Rachel Loewy; Gina Poelke; Joseph Ventura; Keith H Nuechterlein; Christine I Hooker; Michael F Green; Mike Merzenich; Sophia Vinogradov
Journal:  Schizophr Res Cogn       Date:  2014-03-01

5.  Emotional granularity and social functioning in individuals with schizophrenia: an experience sampling study.

Authors:  David Kimhy; Julia Vakhrusheva; Samira Khan; Rachel W Chang; Marie C Hansen; Jacob S Ballon; Dolores Malaspina; James J Gross
Journal:  J Psychiatr Res       Date:  2014-02-11       Impact factor: 4.791

6.  Gender Differences in Social Cognition: A Cross-Sectional Pilot Study of Recently Diagnosed Patients with Schizophrenia and Healthy Subjects.

Authors:  Guillem Navarra-Ventura; Sol Fernandez-Gonzalo; Marc Turon; Esther Pousa; Diego Palao; Narcis Cardoner; Merce Jodar
Journal:  Can J Psychiatry       Date:  2017-12-07       Impact factor: 4.356

7.  Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study.

Authors:  Charlie A Davidson; Danijela Piskulic; Jean Addington; Kristen S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; Scott W Woods; Jason K Johannesen
Journal:  Schizophr Res       Date:  2018-05-08       Impact factor: 4.939

8.  Reduced mirror neuron activity in schizophrenia and its association with theory of mind deficits: evidence from a transcranial magnetic stimulation study.

Authors:  Urvakhsh Meherwan Mehta; Jagadisha Thirthalli; Rakshathi Basavaraju; Bangalore N Gangadhar; Alvaro Pascual-Leone
Journal:  Schizophr Bull       Date:  2013-11-09       Impact factor: 9.306

9.  Social and nonsocial cognition in bipolar disorder and schizophrenia: relative levels of impairment.

Authors:  Junghee Lee; Lori Altshuler; David C Glahn; David J Miklowitz; Kevin Ochsner; Michael F Green
Journal:  Am J Psychiatry       Date:  2013-03       Impact factor: 18.112

10.  Neurodevelopmental Genomic Strategies in the Study of the Psychosis Spectrum.

Authors:  Raquel E Gur
Journal:  Nebr Symp Motiv       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.